News & Updates
Filter by Specialty:
Netarsudil use for glaucoma may cause punctal stenosis
Use of topical netarsudil 0.02% for the treatment of glaucoma results in the development of reversible punctal stenosis, a recent study has found. This inflammation-mediated stenosis can cause tearing and related symptoms and may lead to treatment discontinuation with sufficient severity.
Netarsudil use for glaucoma may cause punctal stenosis
28 Jun 2022
Fatigue persists as lung function improves months after COVID-19 hospitalization
COVID-19 patients remain on the recovery phase 6 months after hospital admission, with persistent fatigue but improving lung function and quality of life, according to a study.
Fatigue persists as lung function improves months after COVID-19 hospitalization
28 Jun 2022
Updated ASCEMBL results boost asciminib potential for CML
In the week-96 analysis of the phase III ASCEMBL trial, the first BCR::ABL1 STAMP* inhibitor asciminib sustained superiority over bosutinib for individuals with CML-CP** who have failed ≥2 lines of prior tyrosine kinase inhibitors (TKIs).
Updated ASCEMBL results boost asciminib potential for CML
28 Jun 2022
Insomnia in children with ADHD affects daytime behaviour and cognitive functioning
Insomnia may play a role in manifestation of attention deficit hyperactivity disorder (ADHD) symptoms and has a negative effect on cognitive abilities of children with ADHD, according to a cross-sectional study by the University of Hong Kong (HKU), the Chinese University of Hong Kong (CUHK) and Alice Ho Miu Ling Nethersole Hospital.
